Deprecated: Creation of dynamic property lastRSS::$cache_dir is deprecated in /www/wwwroot/forexconverter.org/00rss.php on line 45
Deprecated: Creation of dynamic property lastRSS::$cache_sqlite is deprecated in /www/wwwroot/forexconverter.org/00rss.php on line 46
Deprecated: Creation of dynamic property lastRSS::$cache_time is deprecated in /www/wwwroot/forexconverter.org/00rss.php on line 47
Deprecated: Creation of dynamic property lastRSS::$rsscp is deprecated in /www/wwwroot/forexconverter.org/lastRSS.php on line 234
Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular . . . Ample evidence exists in support of the potent anti-inflammatory properties of statins In cell studies and animal models statins exert beneficial cardiovascular effects By inhibiting intracellular isoprenoids formation, statins suppress vascular
The Effects of Statins on Cardiovascular and . . . - ScienceDirect Statins are well-established for their treatment of cardiovascular disease (CVD) due to their cholesterol-lowering effects and potential anti-inflammatory properties Although previous systematic reviews demonstrate that statins reduce inflammatory biomarkers in the secondary prevention of CVD, none examine their effects on cardiac and inflammatory biomarkers in a primary prevention setting
Evaluation of the anti-inflammatory potential of atorvastatin targeting . . . The inflammatory response is primarily mediated through the activation of immune cells and the subsequent release of proinflammatory cytokines, such as interleukin-6 (IL-6), interleukin-1 beta (IL-1β), and tumor necrosis factor-alpha (TNF-α) 5 – 8
Effect of statins on the plasma serum levels of inflammatory . . . - Springer Therefore, a systematic review and meta-analysis of randomized clinical trials were conducted to illuminate the effect of statins on serum levels of TNF-α, MCP-1, VCAM1, and IL-6 in patients with cardiovascular diseases (CVDs) Methods To find eligible studies, a systematic literature search of the main databases were conducted up to July 2021
Publication: Statins help reduce inflammation in chronic disease It was found that statins significantly reduce key markers of inflammation (IL-6, TNF-α, and CRP) Among all statins, atorvastatin had the strongest impact on reducing IL-6 and TNF-α, especially when taken for more than four months
Statins reduce vascular inflammation in atherogenesis: A review of . . . In line with this, a recent report showed statins to suppress pro-inflammatory cytokine levels in the aortic wall even in absence of atherosclerosis and to promote macrophage shift towards the protective M2 subset (van der Meij et al , 2013)
Molecular and Immunomodulatory Mechanisms of Statins in . . . - PubMed The lipid-lowering effect of statins stems from their ability to suppress HMG-CoA reductase, a crucial enzyme in cholesterol synthesis; however, their pleiotropic effects include modulation of critical inflammatory pathways such as the inhibition of NF-κB signalling, a reduction in pro-inflammatory cytokine production, and enhancement of
Effects of statins on adhesion molecule expression in endothelial cells In view of the discrepant results presented for the effect of statins on leukocyte adhesion molecule expression by cytokine activated EC, we initiated a study to determine to what extent simvastatin, fluvastatin and pravastatin modified adhesion molecule expression in EC before or after treatment with TNF-α or LPS We also set out experiments to investigate the mechanism of the statin effect
Anti-inflammatory effect of simvastatin by impeding TNF-α and . . . Statins regulate innate immune system by exerting effect on endothelial cells, macrophages, natural killer cells, and neutrophils [40] Furthermore, studies have shown that statins produce anti-inflammatory effect by decreasing protein prenylation ultimately reduce expression of transcription factors TNF-α and IL-1ß